Q&A - Sodium–glucose co-transporter 2 inhibition and the heart: lessons from cardiovascular outcomes trials in Type 2 diabetes.
26 May 2019 (13:35 - 13:45)
Organised by:
About the speakers
St. Michael's Hospital, Toronto (Canada)
London (United Kingdom of Great Britain & Northern Ireland)
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
Hospital Lariboisiere, Paris (France)
5 More presentations in this session
Professor M. Pfeffer (Boston, US)
Professor S. Verma (Toronto, CA)
Professor M. Cowie (London, GB)
Doctor S. Wiviott (Boston, US)
Professor A. Mebazaa (Paris, FR)
Professor M. Cowie (London, GB)
Access the full session
The Event
Heart Failure 2019
26 May 2019
13:35 CET
You may be interested in
Congress Presentation
31 August 2019
Congress Presentation
